Long COVID Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a confirmed COVID-19 infection.
- People whose symptoms have continued for more than 3 months after their COVID-19 infection.
- People who are experiencing at least one of the symptoms listed in the trial's clinical assessment checklist (confirm with trial site for the full list of qualifying symptoms).
Who may not be able to join:
- People whose symptoms were already present before they got COVID-19.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Patricia Fanlo Mateo, MD, PhD, Hospital Universitario de Navarra. Pamplona. Spain
Phone: +3484822163
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Describe the demographic, clinical and analytical characteristics of patients with persistent COVID in our setting.; Establish the prevalence of different symptoms, complications and/or medium- to long-term sequelae of COVID-19 in Navarre.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.